News

The Pharma Letter44m
Gates Foundation commits $2.5 billion to women’s health research
The Gates Foundation announced a $2.5 billion commitment through 2030 to accelerate research and development (R&D) focused ...
The Pharma Letter17h
The week in pharma: action, reaction and insight – week to August 8
Significant news last week included Vertex Pharmaceuticals dropping development of its acute pain candidate VX-993 following ...